Position in PFE
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$43,839,446
-$6,480,391 QoQ
Shares Held
1,820,575
+1.6% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#190
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cambridge Investment Research Advisors, Inc. holds $708,681,337 across 15 Drug Manufacturers - General names. PFE ranks #5 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
181,813 | $218,071,984 | |
| 2 | ABBV |
AbbVie Inc.
|
566,381 | $142,524,114 | |
| 3 | JNJ |
Johnson & Johnson
|
486,640 | $123,591,960 | |
| 4 | MRK |
Merck & Co., Inc.
|
469,217 | $60,294,384 | |
| 5 | PFE |
Pfizer Inc
This page
|
1,820,575 | $43,839,446 | |
| 6 | AMGN |
Amgen Inc
|
107,825 | $39,045,589 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
434,411 | $25,030,761 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
144,124 | $18,208,626 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43,839,446 | 1,820,575 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $50,319,837 | 1,792,017 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $45,367,800 | 1,822,000 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $46,187,264 | 1,812,687 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $46,092,408 | 1,901,502 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $45,111,028 | 1,780,230 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $45,524,233 | 1,715,953 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $50,580,058 | 1,747,756 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $49,709,407 | 1,776,605 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $47,207,217 | 1,701,161 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $45,766,081 | 1,589,652 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $48,202,146 | 1,453,185 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $56,746,527 | 1,547,070 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $53,932,948 | 1,321,886 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $69,928,355 | 1,364,722 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $59,814,625 | 1,366,879 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $72,682,817 | 1,386,283 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $71,397,094 | 1,379,121 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $90,944,735 | 1,540,131 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $62,932,963 | 1,463,217 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $62,260,014 | 1,589,888 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $53,790,246 | 1,484,688 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $54,788,335 | 1,488,409 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $53,223,131 | 1,450,223 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $43,391,309 | 1,326,950 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $42,704,420 | 1,308,348 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||